title: The role of decreased retinoblastoma protein expression in acute myelomonocytic and monoblastic leukemias.
abstract: The results of different investigators show that lack of p105 expression is relatively common in human myeloid leukemias, especially in monocytic leukemias. This suggests that loss of p105 expression could contribute to the altered growth control of these cells. So far no clear data exist which show that low p105 levels in AML blasts predict a poor therapy outcome. Therefore it is not very likely that p105 expression will become a strong prognostic factor for the different treatment strategies in AML.
authors.affiliation: Dept. of Haematology/Oncology, Philipps University, Marburg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Weide
authors.forename: B
authors.initials: B
authors.lastname: Parviz
authors.forename: K H
authors.initials: KH
authors.lastname: Pflüger
authors.forename: H
authors.initials: H
authors.lastname: Köppler
authors.forename: B
authors.initials: B
authors.lastname: Wörmann
authors.forename: M
authors.initials: M
authors.lastname: Zühlsdorf
authors.forename: K
authors.initials: K
authors.lastname: Havemann
mesh_terms: D015139:Blotting, Southern; D015870:Gene Expression; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000378:metabolism*; D015479:Leukemia, Myelomonocytic, Acute / Q000378:metabolism*; D016160:Retinoblastoma Protein / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
chemical_list: D016160:Retinoblastoma Protein